B
CFRX

Bailard’s ContraFect Corporation CFRX Stock Holding History

Bailard’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-359
Closed -$105K – 845
2022
Q1 		$105K Buy
+359
New +$87.3K ﹤0.01% 695

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bailard's CFRX Position: Q2 2022 in Review

Bailard sold out of ContraFect Corporation (CFRX) in Q2 2022, closing a stake of 359 shares — an estimated $105K sold.

Bailard first reported a position in CFRX in Q1 2022 and held it in 1 quarter. The position peaked at $105K in Q1 2022. 53 funds tracked by Wall St. Rank hold CFRX as of Q2 2022.

  • Bailard reported no remaining ContraFect Corporation position as of Q2 2022 after selling out during the quarter.
  • Bailard sold 359 ContraFect Corporation shares in Q2 2022, an estimated $105K.
  • Bailard first reported a position in ContraFect Corporation in Q1 2022 and held it in 1 quarter.
  • Bailard's ContraFect Corporation position peaked at $105K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2022.

Based on Bailard's 13F filing for Q2 2022, filed 27 Jul 2022.